title: Development of an aerosol model of Cryptococcus reveals humidity as an important factor affecting the viability of Cryptococcus during aerosolization.
abstract: Cryptococcus is an emerging global health threat that is annually responsible for over 1,000,000 infections and one third of all AIDS patient deaths. There is an ongoing outbreak of cryptococcosis in the western United States and Canada. Cryptococcosis is a disease resulting from the inhalation of the infectious propagules from the environment. The current and most frequently used animal infection models initiate infection via liquid suspension through intranasal instillation or intravenous injection. These models do not replicate the typically dry nature of aerosol exposure and may hinder our ability to decipher the initial events that lead to clearance or the establishment of infection. We have established a standardized aerosol model of murine infection for the human fungal pathogen Cryptococcus. Aerosolized cells were generated utilizing a Collison nebulizer in a whole-body Madison Chamber at different humidity conditions. The aerosols inside the chamber were sampled using a BioSampler to determine viable aerosol concentration and spray factor (ratio of viable aerosol concentration to total inoculum concentration). We have effectively delivered yeast and yeast-spore mixtures to the lungs of mice and observed the establishment of disease. We observed that growth conditions prior to exposure and humidity within the Madison Chamber during exposure can alter Cryptococcus survival and dose retained in mice.
authors.affiliation: Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, USA. deborah.springer@duke.edu
authors.forename: Deborah J
authors.initials: DJ
authors.lastname: Springer
authors.forename: Divey
authors.initials: D
authors.lastname: Saini
authors.forename: Edmond J
authors.initials: EJ
authors.lastname: Byrnes
authors.forename: Joseph
authors.initials: J
authors.lastname: Heitman
authors.forename: Richard
authors.initials: R
authors.lastname: Frothingham
mesh_terms: D000336:Aerosols; D000818:Animals; D003453:Cryptococcosis / Q000382:microbiology*; D056285:Cryptococcus gattii / Q000502:physiology*; D003455:Cryptococcus neoformans / Q000502:physiology*; D004195:Disease Models, Animal; D006813:Humidity; D051379:Mice; D008810:Mice, Inbred C57BL; D009330:Nebulizers and Vaporizers; D010316:Particle Size
chemical_list: D000336:Aerosols
references.citation: J Clin Microbiol. 1999 Apr;37(4):1170-2
references.pmid: 10074545
references.citation: J Pharmacol Toxicol Methods. 2004 Jan-Feb;49(1):39-55
references.pmid: 14670693
references.citation: Infect Immun. 2006 Jul;74(7):3817-24
references.pmid: 16790753
references.citation: J R Soc Interface. 2009 Dec 6;6 Suppl 6:S737-46
references.pmid: 19773291
references.citation: Appl Environ Microbiol. 1981 May;41(5):1225-9
references.pmid: 7020595
references.citation: Infect Immun. 2009 Aug;77(8):3491-500
references.pmid: 19451235
references.citation: Infect Immun. 1999 May;67(5):2218-24
references.pmid: 10225877
references.citation: Eukaryot Cell. 2009 Apr;8(4):595-605
references.pmid: 19181873
references.citation: Mycoses. 2008 May;51(3):258-65
references.pmid: 18399907
references.citation: PLoS One. 2011 Feb 24;6(2):e16936
references.pmid: 21383989
references.citation: Appl Environ Microbiol. 2012 Mar;78(6):1666-9
references.pmid: 22226954
references.citation: Am Rev Respir Dis. 1987 Nov;136(5):1242-7
references.pmid: 3314617
references.citation: Microbes Infect. 2009 Feb;11(2):205-14
references.pmid: 19073275
references.citation: Microbiol Immunol. 2009 Feb;53(2):112-6
references.pmid: 19291095
references.citation: J Infect. 2007 Jan;54(1):e5-8
references.pmid: 16678269
references.citation: Comp Med. 2007 Feb;57(1):9-17
references.pmid: 17348287
references.citation: Infect Immun. 1980 Aug;29(2):633-41
references.pmid: 7011980
references.citation: Respir Res. 2008 Jan 22;9:9
references.pmid: 18211687
references.citation: Infect Immun. 1977 Sep;17(3):634-8
references.pmid: 332630
references.citation: Infect Immun. 2009 Mar;77(3):1061-70
references.pmid: 19114546
references.citation: Microbiology (Reading). 2008 Jul;154(Pt 7):1939-1948
references.pmid: 18599822
references.citation: PLoS One. 2013;8(1):e55579
references.pmid: 23383232
references.citation: J Infect Dis. 2005 Sep 1;192(5):888-92
references.pmid: 16088839
references.citation: Am J Physiol. 1947 Jul 1;150(1):78-83
references.pmid: 20252829
references.citation: J Bacteriol. 1964 Jun;87:1364-8
references.pmid: 14188714
references.citation: Mycoses. 2010 Nov;53(6):509-14
references.pmid: 19627508
references.citation: Curr Biol. 2006 Nov 7;16(21):2161-5
references.pmid: 17084702
references.citation: Infect Immun. 2009 Aug;77(8):3450-7
references.pmid: 19487474
references.citation: J Infect. 2005 Jul;51(1):10-6
references.pmid: 15979484
references.citation: J Pharmacol Toxicol Methods. 2011 Mar-Apr;63(2):143-9
references.pmid: 20849964
references.citation: Aerobiologia (Bologna). 2007;23(4):239-248
references.pmid: 32214623
references.citation: Am J Med Sci. 2012 Jun;343(6):510-1
references.pmid: 22314106
references.citation: Infect Immun. 2009 Oct;77(10):4284-94
references.pmid: 19635827
references.citation: Med Mycol. 1998 Dec;36(6):419-24
references.pmid: 10206753
references.citation: Future Microbiol. 2012 Mar;7(3):319-29
references.pmid: 22393887
references.citation: mBio. 2012 May 08;3(3):
references.pmid: 22570277
references.citation: N Engl J Med. 2013 Feb 14;368(7):589-92
references.pmid: 23343038
references.citation: Antimicrob Agents Chemother. 2004 May;48(5):1908-11
references.pmid: 15105158
references.citation: J Hyg (Lond). 1952 Mar;50(1):53-68
references.pmid: 14908062
references.citation: Indian J Pathol Microbiol. 2008 Apr-Jun;51(2):296-7
references.pmid: 18603716
references.citation: Eur J Immunol. 2003 Jun;33(6):1744-53
references.pmid: 12778493
references.citation: Clin Infect Dis. 2012 Sep;55(6):789-98
references.pmid: 22670042
references.citation: Emerg Infect Dis. 2012 Oct;18(10):1618-24
references.pmid: 23017442
references.citation: Infect Immun. 2009 Sep;77(9):3749-58
references.pmid: 19564388
references.citation: Nan Fang Yi Ke Da Xue Xue Bao. 2012 Feb;32(2):169-72
references.pmid: 22381750
references.citation: PLoS One. 2012;7(10):e46789
references.pmid: 23056454
references.citation: Mycopathologia. 2012 Jul;174(1):87-92
references.pmid: 22057831
references.citation: Antimicrob Agents Chemother. 2007 Apr;51(4):1373-9
references.pmid: 17296745
references.citation: Microb Ecol. 2009 May;57(4):757-65
references.pmid: 18850241
references.citation: Eukaryot Cell. 2007 Jun;6(6):949-59
references.pmid: 17449657
references.citation: Infect Immun. 2004 Feb;72(2):1065-71
references.pmid: 14742554
references.citation: Mycologia. 1976 Jul-Aug;68(4):943-6
references.pmid: 790173
references.citation: PLoS One. 2010 Jun 07;5(6):e10978
references.pmid: 20539754
references.citation: Appl Environ Microbiol. 2007 Mar;73(5):1433-43
references.pmid: 17194837
references.citation: Front Cell Infect Microbiol. 2012 Oct 11;2:126
references.pmid: 23087911
references.citation: Infect Immun. 2007 Oct;75(10):4792-8
references.pmid: 17664261
references.citation: Mycopathologia. 2010 Oct;170(4):279-85
references.pmid: 20306144
references.citation: Antimicrob Agents Chemother. 2006 Oct;50(10):3501-3
references.pmid: 17005844
references.citation: Infect Immun. 1992 Feb;60(2):602-5
references.pmid: 1730495
references.citation: Appl Environ Microbiol. 1990 Nov;56(11):3463-7
references.pmid: 2268156
references.citation: Mycopathologia. 2012 Jun;173(5-6):337-46
references.pmid: 22081254
references.citation: Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12980-5
references.pmid: 19651610
references.citation: Mycoses. 2012 May;55(3):262-8
references.pmid: 21815945
references.citation: Emerg Infect Dis. 2005 Nov;11(11):1686-92
references.pmid: 16318719
references.citation: Mycopathologia. 1998-1999;144(1):21-7
references.pmid: 10422270
references.citation: Infect Immun. 2009 Jul;77(7):2783-94
references.pmid: 19451250
references.citation: PLoS Pathog. 2007 Oct 19;3(10):1470-6
references.pmid: 17953482
references.citation: Cell Host Microbe. 2007 Jun 14;1(4):263-73
references.pmid: 18005707
references.citation: Pediatr Infect Dis J. 2011 Dec;30(12):1111-4
references.pmid: 21814154
references.citation: Am J Pathol. 2005 Feb;166(2):421-32
references.pmid: 15681826
references.citation: Microbes Infect. 2006 Apr;8(4):1006-15
references.pmid: 16487740
references.citation: J Immunol. 1997 Jan 15;158(2):790-9
references.pmid: 8992996
references.citation: Lancet. 2001 May 12;357(9267):1507
references.pmid: 11377614
references.citation: J Med Vet Mycol. 1997 Jul-Aug;35(4):263-9
references.pmid: 9292423
references.citation: Med Mycol. 2001;39 Suppl 1:19-30
references.pmid: 11800266
references.citation: Microbes Infect. 2002 Nov;4(14):1427-38
references.pmid: 12475633
references.citation: AIDS. 2009 Feb 20;23(4):525-30
references.pmid: 19182676
references.citation: Cell Microbiol. 2013 Mar;15(3):403-11
references.pmid: 23127124
references.citation: Infect Immun. 2009 Oct;77(10):4345-55
references.pmid: 19620339
references.citation: Zentralbl Bakteriol Orig A. 1975 Jul;232(2-3):355-64
references.pmid: 1101587